HealthyNCT02537301
Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by a Group of Doctors
An observational study of Healthy, run by Air Force Military Medical University, China at 1 site in China.
Trial summary
Group chat through the platform of mobile social networking provides an easily accessible, real-time and interactive channel for communication. With the help of mobile social app, a group of doctors with similar interests can share valuable cases, important papers and opinions through multiple media types (texts… Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Healthy
- What is being tested?
- joining in the platform
- How many people
- 60 participants
- Where
- 1 siteChina
- Study dates
- Jun 2015to Jan 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases and joined in a chatting group through a mobile social app
Who may be able to join
- Doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases and joined in a chatting group in a mobile social app (Wechat).
Who cannot join
- Unable to join in the chatting group
- Unable to finish the questionaire
- Denying participating in the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by Trainees After Finishing ERCP Training
Group chat through the platform of mobile social networking provides an easily accessible, real-time and interactive channel for communication. With the help of mobile social app, a group of doctors with similar interests can share valuable cases, important papers and opinions through multiple media types (texts, images, and videos). It remains unknown what activities of Endoscopic Retrograde Cholangiopancreatography(ERCP) doctors on a group-chat platform are.
In the beginning of 2013, a chatting group on Wechat (the most popular mobile social app in China), focusing on ERCP, was created. All the doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases were invited to join in the platform. The contents in the chatting group were analyzed. The relationships between the chatting activities of ERCP doctors and the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) were investigated.
- Conditions
- Healthy
- Being tested
- joining in the platform
- Keywords
- Endoscopic Retrograde Cholangiopancreatography, social networking, group chat
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
joining in the platformOther
The activities (contents, chatting frequency etc.) of ERCP doctors on the chatting group were retrospectively extracted. The data related to the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) by ERCP doctors were collected by a questionaire.
| Study group | Role | What they receive |
|---|---|---|
| ERCP-chat group | All the doctors who finished their ERCP training in Xijing Hospital of Digestive Diseases and were invited to join in a chatting group in a mobile social app (Wechat). Receives: Other: joining in the platform |
What is being measured
The primary outcome is the main question the study is designed to answer.
Chatting frequency
Measured: 1 year
Secondary outcomes (3)
Difficulty grade of the discussed case
Measured: 1 year
Number of biliary duct-related cases
Measured: 1 year
ERCP performance volumes
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Sep 2015 (estimated)
- Study startJun 2015
- Primary completionJan 2016
- Study completionJan 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Retrospective
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Air Force Military Medical University, China
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yanglin Pan, Air Force Military Medical University, China
- Investigators
- Yanglin Pan, Principal investigator, Xijing Hospital of Disgestive Diseases.The Fourth Military University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02537301
- Sponsor's protocol ID
- 20150611-4
- Status last verified
- Jan 2016
- First submitted
- 13 Aug 2015
- Last updated
- 12 Jan 2016
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Blackmur JP, Clement RG, Brady RR, Oliver CW. Surgical training 2.0: How contemporary developments in information technology can augment surgical training. Surgeon. 2013 Apr;11(2):105-12. doi: 10.1016/j.surge.2012.12.001. Epub 2013 Jan 9.
PubMed 23312553Ang TL, Cheng J, Khor JL, Mesenas SJ, Vu KF, Wong WK; Endoscopic Retrograde Cholangiopancreatography (ERCP). Guideline on training and credentialing in endoscopic retrograde cholangiopancreatography. Singapore Med J. 2011 Sep;52(9):654-7.
PubMed 21947141Pan Y, Zhao L, Leung J, Zhang R, Luo H, Wang X, Liu Z, Wan B, Tao Q, Yao S, Hui N, Fan D, Wu K, Guo X. Appropriate time for selective biliary cannulation by trainees during ERCP--a randomized trial. Endoscopy. 2015 Aug;47(8):688-95. doi: 10.1055/s-0034-1391564. Epub 2015 Mar 6.
PubMed 25750038
Study at a glance
From the registry record, last updated by the sponsor on 12 Jan 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by Trainees After Finishing ERCP Training
- ClinicalTrials.gov ID
- NCT02537301
- Acronym / sponsor ID
- 20150611-4
- Conditions
- Healthy
- Keywords
- Endoscopic Retrograde Cholangiopancreatography, social networking, group chat
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Air Force Military Medical University, ChinaUniversity, hospital or other
- Study start
- Jun 2015
- Primary completion
- Jan 2016 (actual)
- Study completion
- Jan 2016 (actual)
- First posted
- 1 Sep 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Group chat through the platform of mobile social networking provides an easily accessible, real-time and interactive channel for communication. With the help of mobile social app, a group of doctors with similar interests can share valuable cases, important papers and opinions through multiple media types (texts, images, and videos). It remains unknown what activities of Endoscopic Retrograde Cholangiopancreatography(ERCP) doctors on a group-chat platform are.
In the beginning of 2013, a chatting group on Wechat (the most popular mobile social app in China), focusing on ERCP, was created. All the doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases were invited to join in the platform. The contents in the chatting group were analyzed. The relationships between the chatting activities of ERCP doctors and the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) were investigated.
Study design
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ERCP-chat group | – | Other: joining in the platformAll the doctors who finished their ERCP training in Xijing Hospital of Digestive Diseases and were invited to join in a chatting group in a mobile social app (Wechat). |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases and joined in a chatting group through a mobile social app
Key inclusion criteria (1 listed)
- Doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases and joined in a chatting group in a mobile social app (Wechat).
Key exclusion criteria (3 listed)
- Unable to join in the chatting group
- Unable to finish the questionaire
- Denying participating in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| joining in the platformThe activities (contents, chatting frequency etc.) of ERCP doctors on the chatting group were retrospectively extracted. The data related to the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) by ERCP doctors were collected by a questionaire. | Other | ERCP-chat group |
Primary outcome
Chatting frequency
Time frame: 1 year
3 secondary outcomes
Difficulty grade of the discussed case
Time frame: 1 year
Number of biliary duct-related cases
Time frame: 1 year
ERCP performance volumes
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jan 2016.
- Results publication: PubMed 23312553Blackmur JP, Clement RG, Brady RR, Oliver CW. Surgical training 2.0: How contemporary developments in information technology can augment surgical training. Surgeon. 2013 Apr;11(2):105-12. doi: 10.1016/j.surge.2012.12.001. Epub 2013 Jan 9.
- Results publication: PubMed 21947141Ang TL, Cheng J, Khor JL, Mesenas SJ, Vu KF, Wong WK; Endoscopic Retrograde Cholangiopancreatography (ERCP). Guideline on training and credentialing in endoscopic retrograde cholangiopancreatography. Singapore Med J. 2011 Sep;52(9):654-7.
- Results publication: PubMed 25750038Pan Y, Zhao L, Leung J, Zhang R, Luo H, Wang X, Liu Z, Wan B, Tao Q, Yao S, Hui N, Fan D, Wu K, Guo X. Appropriate time for selective biliary cannulation by trainees during ERCP--a randomized trial. Endoscopy. 2015 Aug;47(8):688-95. doi: 10.1055/s-0034-1391564. Epub 2015 Mar 6.
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yanglin Pan principal investigator
Xijing Hospital of Disgestive Diseases.The Fourth Military University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy, run by Air Force Military Medical University, China at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Chatting frequency (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02537301, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2016.